{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:00:24Z","timestamp":1790125224884,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["T-A-009"],"award-info":[{"award-number":["T-A-009"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019870","name":"Cancer Foundation of China","doi-asserted-by":"publisher","award":["LC2022B24"],"award-info":[{"award-number":["LC2022B24"]}],"id":[{"id":"10.13039\/501100019870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0502200"],"award-info":[{"award-number":["2023ZD0502200"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["JQ23032"],"award-info":[{"award-number":["JQ23032"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7252119"],"award-info":[{"award-number":["7252119"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203688"],"award-info":[{"award-number":["82203688"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573522"],"award-info":[{"award-number":["82573522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573118"],"award-info":[{"award-number":["82573118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373060"],"award-info":[{"award-number":["82373060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218387","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:45:07Z","timestamp":1772178307000},"page":"218387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["PANX1-mediated NLRP3 inflammasome activation promotes an adaptive doxorubicin resistance through IL-1\u03b2 signaling in breast cancer"],"prefix":"10.1016","volume":"645","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9064-9740","authenticated-orcid":false,"given":"Chenxuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218387_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218387_bib2","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.canlet.2026.218387_bib3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(23)00285-4","article-title":"Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials","volume":"401","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218387_bib4","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade","volume":"18","author":"Kathawala","year":"2014","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218387_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1470-2045(00)00032-2","article-title":"Effect of the breast-cancer resistance protein on atypical multidrug resistance","volume":"1","author":"Lage","year":"2000","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218387_bib6","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-18-3510","article-title":"CKLF1 enhances inflammation-mediated carcinogenesis and prevents doxorubicin-induced apoptosis via IL6\/STAT3 signaling in HCC","volume":"25","author":"Liu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218387_bib7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/OTT.S60114","article-title":"Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis","volume":"7","author":"Vyas","year":"2014","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2026.218387_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218387_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218387_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-025-01763-6","article-title":"Inflammasomes and pyroptosis in cancer: mechanisms and therapeutic advances","author":"Seo","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218387_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13046-025-03366-y","article-title":"Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential","volume":"44","author":"Singh","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218387_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","article-title":"NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer","volume":"28","author":"Faria","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2026.218387_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.10.014","article-title":"Interleukin-1\u03b1 release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity","volume":"42","author":"H\u00e4nggi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218387_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121967","article-title":"Pannexin1 is associated with enhanced epithelial-to-mesenchymal transition in human patient breast cancer tissues and in breast cancer cell lines","volume":"11","author":"Jalaleddine","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218387_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ncb3194","article-title":"Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival","volume":"17","author":"Furlow","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218387_bib16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.trecan.2021.07.002","article-title":"Pannexin biology and emerging linkages to cancer","volume":"7","author":"Laird","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218387_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41389-018-0100-4","article-title":"Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function","volume":"7","author":"Xiang","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2026.218387_bib18","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/0008-5472.CAN-06-1396","article-title":"Tumor-suppressive effects of pannexin 1 in C6 glioma cells","volume":"67","author":"Lai","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218387_bib19","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1038\/s41467-024-52394-3","article-title":"Basal-to-inflammatory transition and tumor resistance via crosstalk with a pro-inflammatory stromal niche","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218387_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.immuni.2015.12.006","article-title":"Compendium of immune signatures identifies conserved and species-specific biology in response to inflammation","volume":"44","author":"Godec","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218387_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218387_bib22","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jama.2011.593","article-title":"A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer","volume":"305","author":"Hatzis","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2026.218387_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1476-4598-13-265","article-title":"Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells","volume":"13","author":"Ebert","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218387_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150876","article-title":"Carbenoxolone upregulates TRAIL\\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in rats","volume":"741","author":"El-Zehery","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218387_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41388-019-1044-7","article-title":"A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma","volume":"39","author":"Salcher","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218387_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187202","article-title":"Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218387_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411898121","article-title":"The C-terminal activating domain promotes pannexin 1 channel opening","volume":"121","author":"Henze","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218387_bib28","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1073\/pnas.1424741112","article-title":"Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance","volume":"112","author":"Carta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218387_bib29","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1113\/JP285228","article-title":"Dual role for pannexin 1 at synapses: regulating functional and morphological plasticity","volume":"603","author":"Casillas Martinez","year":"2024","journal-title":"J. Physiol."},{"key":"10.1016\/j.canlet.2026.218387_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2026.218387_bib31","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1038\/srep04576","article-title":"ATP and potassium ions: a deadly combination for astrocytes","volume":"4","author":"Jackson","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218387_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218387_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-11-87","article-title":"IL-1\u03b2 promotes stemness and invasiveness of colon cancer cells through Zeb1 activation","volume":"11","author":"Li","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218387_bib34","doi-asserted-by":"crossref","first-page":"362.e312","DOI":"10.1016\/j.ajog.2011.05.035","article-title":"Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells","volume":"205","author":"Li","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2026.218387_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218387_bib36","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/jcp.25944","article-title":"Role of adenosine signaling in the pathogenesis of breast cancer","volume":"233","author":"Bahreyni","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218387_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122851","article-title":"Pannexin-1 expression in tumor cells correlates with colon cancer progression and survival","volume":"351","author":"Fierro-Arenas","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2026.218387_bib38","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41388-020-01623-2","article-title":"Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK","volume":"40","author":"Xiang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218387_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114385","article-title":"P2X7 receptor and the NLRP3 inflammasome: partners in crime","volume":"187","author":"Pelegrin","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218387_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1083\/jcb.201503066","article-title":"mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis","volume":"210","author":"Bao","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218387_bib41","article-title":"Novel Pannexin 1 isoform is increased in cancer","author":"O'Donnell","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.canlet.2026.218387_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.breast.2022.06.007","article-title":"Anthracyclines in the treatment of early breast cancer friend or foe?","volume":"65","author":"Vuger","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.canlet.2026.218387_bib43","doi-asserted-by":"crossref","first-page":"eabl6781","DOI":"10.1126\/scisignal.abl6781","article-title":"Gasdermins and pannexin-1 mediate pathways of chemotherapy-induced cell lysis in hematopoietic malignancies","volume":"15","author":"Zhou","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2026.218387_bib50","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Mathias Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218387_bib44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1535-7163.MCT-10-0106","article-title":"Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines","volume":"9","author":"Holbeck","year":"2010","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218387_bib45","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1038\/s41467-025-58511-0","article-title":"Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218387_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.04.003","article-title":"Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays","volume":"185","author":"Chen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218387_bib47","article-title":"Integrated chromatin accessibility and transcriptome landscapes of doxorubicin-resistant breast cancer cells","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218387_bib48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.canlet.2026.218387_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz1723","article-title":"Patient-derived tumor-like cell clusters for drug testing in cancer therapy","volume":"12","author":"Yin","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:47:23Z","timestamp":1776098843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"alternative-id":["S0304383526001503"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218387","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PANX1-mediated NLRP3 inflammasome activation promotes an adaptive doxorubicin resistance through IL-1\u03b2 signaling in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218387"}}